Lipoprotein(a) in clinical practice: What clinicians need to know.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41184077.
- Also identified by DOI 10.3949/ccjm.92a.25020.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Elevated lipoprotein(a) is an independent risk factor for atherosclerotic cardiovascular disease and aortic valve stenosis. Current lipid-lowering treatments have a minimal impact on lipoprotein(a) levels, but emerging therapies show promise, and ongoing phase 3 trials are evaluating their effect on cardiovascular outcomes. This review summarizes evidence on risk, screening strategies, and evolving therapies for elevated lipoprotein(a).
Medical subject headings
- Lipoprotein(a)
- Atherosclerosis
- Cardiovascular Diseases